Cardiovascular Risk Factors in Middle Eastern Patients With Stroke

NCT07298668 | Not Yet Recruiting DMC

• 1 other identifier: JOCVA1.NOV2025/2
• Study Type: observational
• Target: 2,000
• Locations: 1 country
• Sites: 1

Brief Summary

Stroke is a well-known a leading cause of death and disability in the Middle East. There remain many knowledge gaps in evaluating the prevalence of risk factors among patients with stroke in the Middle East. Unravelling the impact of these risk factors and controlling them can positively lower the incidence of stroke. Disparities in stroke risk factors, may well be related to ethnicity of the Middle Eastern populations , will be compared with those among stroke patients in the western literature.

Conditions

Stroke; Low-Density-Lipoprotein-cholesterol Level; Risk Factors

Keywords

Stroke; Risk factors

Outcome Measures

Primary Outcomes (5)

• Prevalence of hypertension in stroke patients (survey interview)

  BP more 140/90 or known diagnosis of high blood pressure or patient already on blood pressure medication

  Baseline

• Prevalence of type 2 diabetes in stroke patients (survey interview)

  HbA1c more than 6.5%, or known diagnosis of type 2 diabetes or patient already on anti diabetes medications

  BASELINE

• Prevalence of elevated serum level of low density lipoprotein cholesterol in stroke patients (survey interview)

  Elevated serum level of low density lipoprotein cholesterol \> 55 mg/dl or patient already on lipid lowering medication

  BASELINE

• Prevalence of current cigarette smoking in stroke patients (survey interview)

  Known current cigarette smoking of any number of cigarettes per day

  BASELINE

• Use of lipid lowering therapy (survey interview)

  Current use of statin, ezitimibe, PCS9 inhibitor of small interfering RNA agent to lower the LDL-C

  BASELINE

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Will enroll adults admitted to the hospital with a working diagnosis of stroke and then the diagnosis is confirmed by a neurologist. Patients ii be interviewed for data collection of 4 risk factors as above in addition to the serum level of LDLC and the use of lipid lowering agents.

You may qualify if:

• Diagnosis of stroke upon admission to the hospital
• Adult aged 18 years or older
• Available lipid profile on hospital admission

You may not qualify if:

• Stroke diagnosis unconfirmed
• age younger than 18 years
• No available lipid profile on admission

Sponsors & Collaborators

• Jordan Collaborating Cardiology Group: lead

Study Sites (1)

Istishari Hospital

Amman, 11184, Jordan

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases

Central Study Contacts

Laith Habahbeh, MD

CONTACT

065001000; a.hammoudeh@istisharihospital.com

Ayman Hammoudeh, MD, FACC

CONTACT

065001000; hammoudeh_ayman@yahoo.com

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 26, 2025
• First Posted: December 23, 2025
• Study Start: December 31, 2025
• Primary Completion (Estimated): December 31, 2026
• Study Completion (Estimated): January 31, 2027
• Last Updated: December 23, 2025

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will share

Locations

JO (1)